ATE322288T1 - Zusammensetzungen zur immunisierung sowie deren verwendung - Google Patents

Zusammensetzungen zur immunisierung sowie deren verwendung

Info

Publication number
ATE322288T1
ATE322288T1 AT02705685T AT02705685T ATE322288T1 AT E322288 T1 ATE322288 T1 AT E322288T1 AT 02705685 T AT02705685 T AT 02705685T AT 02705685 T AT02705685 T AT 02705685T AT E322288 T1 ATE322288 T1 AT E322288T1
Authority
AT
Austria
Prior art keywords
compositions
immunization
present
methods
provides
Prior art date
Application number
AT02705685T
Other languages
English (en)
Inventor
Daryll A Emery
Darren E Straub
Donavan E Zammert
Gayla K Kallevig
Original Assignee
Epitopix Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26947345&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE322288(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Epitopix Llc filed Critical Epitopix Llc
Application granted granted Critical
Publication of ATE322288T1 publication Critical patent/ATE322288T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/739—Lipopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/823—Bacterial vaccine for bovine species, e.g. cattle
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/824—Bacterial vaccine for ovine species, e.g. sheep
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/825—Bacterial vaccine for porcine species, e.g. swine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/826—Bacterial vaccine for avian species, e.g. poultry or other birds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/827—Bacterial vaccine for fish
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/828—Bacterial vaccine for canidae or mustelidae, e.g. dogs, foxes, minks
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/829—Bacterial vaccine for equine species, e.g. horses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT02705685T 2001-01-03 2002-01-03 Zusammensetzungen zur immunisierung sowie deren verwendung ATE322288T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25950401P 2001-01-03 2001-01-03
US26289601P 2001-01-19 2001-01-19

Publications (1)

Publication Number Publication Date
ATE322288T1 true ATE322288T1 (de) 2006-04-15

Family

ID=26947345

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02705685T ATE322288T1 (de) 2001-01-03 2002-01-03 Zusammensetzungen zur immunisierung sowie deren verwendung

Country Status (14)

Country Link
US (16) US20030036639A1 (de)
EP (1) EP1353689B9 (de)
AT (1) ATE322288T1 (de)
AU (1) AU2002239820C1 (de)
BR (1) BR0206293B1 (de)
CA (2) CA2433561C (de)
CY (1) CY1105563T1 (de)
DE (1) DE60210413T2 (de)
DK (1) DK1353689T3 (de)
ES (1) ES2265488T3 (de)
MX (1) MXPA03006038A (de)
NZ (1) NZ526786A (de)
PT (1) PT1353689E (de)
WO (1) WO2002053180A2 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830479A (en) * 1994-02-09 1998-11-03 Willmar Poultry Company, Inc. Active immunization using a siderophore receptor protein
WO1995021627A1 (en) * 1994-02-09 1995-08-17 Willmar Poultry Company, Inc. Active immunization using a siderophore receptor protein
CA2433561C (en) * 2001-01-03 2014-04-01 Willmar Poultry Company, Inc. Compositions including gram negative siderophore receptor proteins and methods of use
AU2004274021B2 (en) * 2003-09-18 2009-08-13 Isis Pharmaceuticals, Inc. 4'-thionucleosides and oligomeric compounds
EP1678316B1 (de) * 2003-09-19 2011-08-17 Epitopix, LLC Campylobacter-polypeptide und verwendungsverfahren
US7544376B2 (en) * 2004-07-30 2009-06-09 Sartec Corporation Methods and compositions for increasing milk production in animals
NZ553315A (en) 2004-08-25 2009-12-24 Epitopix Llc Fusobacterium polypeptides and methods of use
EP2431382A1 (de) 2005-01-21 2012-03-21 Epitopix, LLC Yersinia ssp., Polypeptide und Verwendungsverfahren
AU2012244060B2 (en) * 2005-02-14 2015-08-20 Epitopix, Llc Polypeptides from staphylococcus aureus and methods of use
NZ560612A (en) * 2005-02-14 2011-01-28 Epitopix Llc Polypeptides from staphylococcus aureus and methods of use
AU2015258239B2 (en) * 2005-02-14 2017-08-17 Epitopix, Llc Polypeptides from staphylococcus aureus and methods of use
WO2007115059A2 (en) * 2006-03-29 2007-10-11 Merial Limited Vaccine against streptococci
CA2652028C (en) * 2006-05-12 2013-07-16 The United States Of America, As Represented By The Secretary Of The Nav Y Secreted campylobacter flagella coregulated proteins as immunogens
AU2009286376B2 (en) * 2008-08-25 2014-03-13 Koninklijke Philips Electronics N.V. Respiratory patient interfaces
EP2411046B1 (de) 2009-03-23 2017-12-06 Epitopix, LLC Polypeptide und immunisierungszusammensetzungen mit gram-prositiven polypeptiden und anwendungsverfahren
WO2011037444A2 (es) * 2009-09-28 2011-03-31 Carlos Alberto Barcelo Rojas Método de palpación de los estadios fisioreproductivos del útero
US20110129479A1 (en) * 2009-12-02 2011-06-02 Tobin Monte B Immunogen selection directed in immunoglobulin packages in plasma and colostrum and method of making and using same
CN102205117B (zh) * 2011-05-19 2013-12-18 新疆维吾尔自治区畜牧科学院兽医研究所 奶牛乳房炎金黄色葡萄球菌-大肠埃希氏菌二联多价疫苗及其制备方法
RU2631924C2 (ru) * 2011-12-22 2017-09-28 Ваксимм Аг Высокопродуктивный способ получения ослабленных штаммов salmonella
US8753643B1 (en) 2012-04-11 2014-06-17 Life-Science Innovations, Llc Spray dried compositions and methods of use
CA3261641A1 (en) 2013-03-13 2025-06-12 Oncour Pharma, Inc. Immune-modifying particles for the treatment of inflammation
US11000582B2 (en) 2015-07-10 2021-05-11 Epitopix, Llc Proteins and immunizing compositions containing klebsiella proteins and methods of use
EP3373964A1 (de) 2015-11-09 2018-09-19 Epitopix, LLC Polypeptide des fusobacteriums und verfahren zur verwendung
US10166280B2 (en) 2016-06-08 2019-01-01 Epitopix, Llc Polypeptides and immunizing compositions containing Bacillus polypeptides and methods of use
US10905748B2 (en) 2018-04-16 2021-02-02 Vets Plus, Inc. Ovotransferrin treatment for the reproductive tract
KR102151962B1 (ko) * 2020-03-24 2020-09-04 안병철 어린 포유동물의 전염성 질병을 예방 또는 치료하기 위한 혈청 조성물의 제조방법, 상기 방법에 의해 제조된 혈청 조성물 및 이의 용도
CN114901293B (zh) * 2020-03-24 2024-09-24 安炳哲 用于预防或治疗幼小的哺乳动物得与黏膜相关的传染性疾病的血清组成物的制造方法、通过该方法制造的血清组成物及其用途
MX2022014213A (es) * 2020-05-14 2022-12-07 Zivo Bioscience Inc Uso del modulador tlr4 en el tratamiento de la coccidiosis.
US20250011375A1 (en) 2021-10-29 2025-01-09 Vaxxinova Us, Inc. Methods and compositions for preventing infection
WO2025054602A1 (en) * 2023-09-08 2025-03-13 The Texas A&M University System Protein for the serological detection of streptococcus equi subspecies equi exposure or infection

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US197869A (en) * 1877-12-04 Improvement in the manufacture of glass buttons
US197350A (en) * 1877-11-20 Improvement in shoes
US4003792A (en) * 1967-07-01 1977-01-18 Miles Laboratories, Inc. Conjugates of acid polysaccharides and complex organic substances
US4167560A (en) * 1977-04-12 1979-09-11 Texas Vet Lab, Inc. Polyvalent shipping fever vaccine
US4748018A (en) * 1984-02-07 1988-05-31 Stolle Research & Development Corp. Method of passive immunization of mammals using avian antibody
US4530963A (en) * 1982-08-20 1985-07-23 Devoe-Holbein International, N.V. Insoluble chelating compositions
US4452775A (en) * 1982-12-03 1984-06-05 Syntex (U.S.A.) Inc. Cholesterol matrix delivery system for sustained release of macromolecules
US4871488A (en) * 1985-04-22 1989-10-03 Albany Medical College Of Union University Reconstituting viral glycoproteins into large phospholipid vesicles
US4663161A (en) * 1985-04-22 1987-05-05 Mannino Raphael J Liposome methods and compositions
US4681761A (en) * 1985-10-24 1987-07-21 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Major iron-regulated protein of Neisseria gonorrhoeae and its use as vaccine
US4981685A (en) * 1986-03-07 1991-01-01 Utah State University Foundation Bacterial extract vaccines for veterinary application
ES2059503T5 (es) 1987-03-24 2000-01-16 Btg International Limited Comp Procedimiento para preparar una vacuna contra pasteurella.
US5885589A (en) * 1988-04-12 1999-03-23 Intervet International B.V. Pasteurella vaccine
FR2644346B1 (fr) 1989-03-20 1994-05-13 Rhone Merieux Vaccins contre les bacteries septicemiques, preparations d'antigenes de bacteries septicemiques, nouvelles bacteries et vecteurs pour la preparation de ces antigenes ou vaccins
US5141743A (en) * 1989-04-27 1992-08-25 University Technologies International, Inc. Method for isolating and purifying transferrin and lactoferrin receptor proteins and vaccines containing the same
US5292869A (en) 1989-04-27 1994-03-08 The Board Of Governors Of The University Method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same
AU4114893A (en) * 1992-04-27 1993-11-29 Michigan State University Method for producing a bacterial vaccine and novel vaccines produced thereby
US5578314A (en) * 1992-05-29 1996-11-26 The Regents Of The University Of California Multiple layer alginate coatings of biological tissue for transplantation
US5534256A (en) * 1992-07-02 1996-07-09 University Of Saskatchewan Haemophilus somnus outer membrane protein extract enriched with iron-regulated proteins
US5439808A (en) * 1993-07-23 1995-08-08 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
WO1995021627A1 (en) * 1994-02-09 1995-08-17 Willmar Poultry Company, Inc. Active immunization using a siderophore receptor protein
US5830479A (en) * 1994-02-09 1998-11-03 Willmar Poultry Company, Inc. Active immunization using a siderophore receptor protein
US5538733A (en) 1994-07-07 1996-07-23 Willmar Poultry Company, Inc. Method of priming an immune response in a one-day old animal
US6121037A (en) 1994-10-18 2000-09-19 Stojiljkovic; Igor Bacterial hemoglobin receptor genes
US6048539A (en) 1995-11-02 2000-04-11 Connaught Laboratories Limited Lactoferrin receptor protein
DE19803453A1 (de) 1998-01-30 1999-08-12 Boehringer Ingelheim Int Vakzine
US6692739B1 (en) * 1998-08-31 2004-02-17 Inhibitex, Inc. Staphylococcal immunotherapeutics via donor selection and donor stimulation
US6682754B2 (en) * 1999-11-24 2004-01-27 Willmar Poultry Company, Inc. Ovo delivery of an immunogen containing implant
US6902747B1 (en) * 2000-05-03 2005-06-07 Westfaliasurge, Inc. Iodine-propylene glycol teat dip
AT410173B (de) 2000-06-08 2003-02-25 Cistem Biotechnologies Gmbh Antigene zusammensetzung
CA2433561C (en) * 2001-01-03 2014-04-01 Willmar Poultry Company, Inc. Compositions including gram negative siderophore receptor proteins and methods of use
AT410798B (de) 2001-01-26 2003-07-25 Cistem Biotechnologies Gmbh Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen
US6720160B2 (en) * 2001-10-11 2004-04-13 Helica Biosystems, Inc. Method for simultaneous detection of multiple microbial antigens in biological specimens from mastitic animals
US6984503B1 (en) * 2002-06-27 2006-01-10 The United States Of America As Represented By The Secretary Of The Agriculture Use of recombinant bovine CD14 in the treatment and prevention of coliform mastitis in dairy cows
EP1678316B1 (de) 2003-09-19 2011-08-17 Epitopix, LLC Campylobacter-polypeptide und verwendungsverfahren
NZ553315A (en) 2004-08-25 2009-12-24 Epitopix Llc Fusobacterium polypeptides and methods of use
EP2431382A1 (de) * 2005-01-21 2012-03-21 Epitopix, LLC Yersinia ssp., Polypeptide und Verwendungsverfahren
NZ560612A (en) * 2005-02-14 2011-01-28 Epitopix Llc Polypeptides from staphylococcus aureus and methods of use
US7913151B1 (en) * 2006-05-26 2011-03-22 Pmc-Sierra, Inc. Forward error correction with self-synchronous scramblers
US11000582B2 (en) * 2015-07-10 2021-05-11 Epitopix, Llc Proteins and immunizing compositions containing klebsiella proteins and methods of use

Also Published As

Publication number Publication date
US20030206922A1 (en) 2003-11-06
US7138125B2 (en) 2006-11-21
US7138124B2 (en) 2006-11-21
DE60210413T2 (de) 2006-09-07
ES2265488T3 (es) 2007-02-16
AU2002239820C1 (en) 2008-07-10
US20130217048A1 (en) 2013-08-22
CY1105563T1 (el) 2010-07-28
US7943150B2 (en) 2011-05-17
US20040197869A1 (en) 2004-10-07
EP1353689A2 (de) 2003-10-22
NZ526786A (en) 2006-02-24
US20170087238A1 (en) 2017-03-30
US20090081236A1 (en) 2009-03-26
US20040197350A1 (en) 2004-10-07
US20110200637A1 (en) 2011-08-18
US7371393B2 (en) 2008-05-13
US8637048B2 (en) 2014-01-28
US20110200616A1 (en) 2011-08-18
EP1353689B1 (de) 2006-04-05
CA2433561C (en) 2014-04-01
US20030211118A1 (en) 2003-11-13
WO2002053180A3 (en) 2003-03-13
CA2708949A1 (en) 2002-07-11
US20060165718A1 (en) 2006-07-27
US8993252B2 (en) 2015-03-31
MXPA03006038A (es) 2005-02-14
US20110206733A1 (en) 2011-08-25
US7160549B2 (en) 2007-01-09
US8282941B2 (en) 2012-10-09
US20090162402A1 (en) 2009-06-25
US20120195898A1 (en) 2012-08-02
BR0206293A (pt) 2005-10-25
US7943151B2 (en) 2011-05-17
US20040265329A1 (en) 2004-12-30
US8575315B2 (en) 2013-11-05
DK1353689T3 (da) 2006-07-31
US7341732B2 (en) 2008-03-11
CA2708949C (en) 2016-03-08
BR0206293B1 (pt) 2015-01-20
DE60210413D1 (de) 2006-05-18
CA2433561A1 (en) 2002-07-11
US20030036639A1 (en) 2003-02-20
AU2002239820B2 (en) 2007-08-23
PT1353689E (pt) 2006-08-31
WO2002053180A2 (en) 2002-07-11
US8425916B2 (en) 2013-04-23
EP1353689B9 (de) 2006-06-28
US7147857B2 (en) 2006-12-12
US20120195899A1 (en) 2012-08-02

Similar Documents

Publication Publication Date Title
ATE322288T1 (de) Zusammensetzungen zur immunisierung sowie deren verwendung
MY131890A (en) Piperidine compounds
IL189629A0 (en) Compositions containing human ctla-4 antibodies
DE60314500D1 (de) Diaminopyrimidine und deren verwendung als angiogenesehemmer
ATE373719T1 (de) Humanisierte antikörper gegen ccr2 und verfahren zur deren verwendung
ID26984A (id) Senyawa-senyawa sulfonamida sebagai antagonis reseptor angiotensin endotelin ganda
BR9916896A (pt) Diaril aminas substituìdas com 1-heterociclo
IL195338A (en) An antibody comprising an FC variant containing amino acid replaces d or e at position 239, a medicament containing it and its use
BR0307833A (pt) Sìntese controlada de ziprasidona e suas composições
EA200601555A1 (ru) Замещенные индазол-о-глюкозиды
BR9916857A (pt) 4 heteroaril diarilaminas
BG108225A (en) Thiohydantoins and use thereof for treating diabetes
DE602004016499D1 (de) Zusammensetzungen und verfahren zur behandlung von entzündlicher darmerkrankung
ATE393775T1 (de) Verfahren zur herstellung von aplidin und neue antitumoralen derivate, verfahren zu deren herstellung und zu deren verwendung
ATE358485T1 (de) Alpha-7-nikotinsäure-rezeptoragonisten und statine in kombination
DE60044247D1 (de) Humane cd80-mutante und zusammensetzungen und methoden zu deren herstellung und verwendung
SE9802937D0 (sv) Novel compounds
ATE369348T1 (de) Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie
NO20011537L (no) Chemokin-reseptorpeptidvaksiner for behandling og forebygging av diabetes
MXPA03007413A (es) Composicion y metodo para tratar enfermedades inflamatorias.
NO20060093L (no) Plate glykoprotein IB alfa-variant fusjonspolypeptider og fremgangsmater for anvendelse derav
TR200503401T1 (tr) Kuetiapin (Quetiapine) Fumarat'ın yeni polimorfları
ATE290857T1 (de) Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen
BG103060A (bg) 19- нор- холан стероиди като неврохимични инициатори на промяната в действието на хипоталамуса причовек
DE69628743D1 (de) Levobupivacain und dessen verwendung als anästhetikum bei schwangeren frauen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1353689

Country of ref document: EP